Brief: Bubs Australia Remains On Track To Meet Regulatory Milestones For Permanent Access To US
21/06/2023 02:03
June 21 (Reuters) - Bubs Australia Ltd BUB.AX :
* REMAINS ON TRACK TO MEET ALL REGULATORY MILESTONES FOR
PERMANENT
ACCESS TO USA MARKET
* BUBS AUSTRALIA LTD SEES USA NET REVENUE TO BE AT UPPER END
OF
PREVIOUS FORECAST RANGE OF BETWEEN A$20M - A$22M IN FY23
* EXPECTS TO RECEIVE FDA'S WRITTEN AUDIT COMPLIANCE REPORT
IN
COMING WEEKS
Source text for Eikon: ID:nASX3XFNSL
Further company coverage: BUB.AX
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump